These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12966621)

  • 1. Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis.
    Manolova I; Dancheva M
    J Rheumatol; 2003 Sep; 30(9):2078-9; author reply 2079-80. PubMed ID: 12966621
    [No Abstract]   [Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis.
    Casari S; Haeney M; Farrand S; Herrick A
    J Rheumatol; 2002 Dec; 29(12):2666-7. PubMed ID: 12465176
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on the article "Hypocomplementemia in systemic sclerosis" by Cuomo G. et al.
    Hudson M; Steele R; Lu Y
    Reumatismo; 2009; 61(2):156-8; author reply 158. PubMed ID: 19633804
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.
    Herrera-Esparza R; Aguilar JL; Saucedo A; González I; López-Robles E; Avalos-Díaz E
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):617-20. PubMed ID: 16164722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).
    Senécal JL; Hénault J; Raymond Y
    J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854
    [No Abstract]   [Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure.
    Huong DL; Papo T; Gatfosse M; Frances C; Godeau P; Beaufils H
    J Rheumatol; 1995 Apr; 22(4):791-2. PubMed ID: 7791189
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis.
    Grypiotis P; Cozzi F; Ruffatti A
    J Rheumatol; 2004 Jul; 31(7):1468-9. PubMed ID: 15229985
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical relevance of antineutrophil cytoplasmic antibodies in Algerian scleroderma patients.
    Tahiat A; Djidjik R; Abdessmed A; Mellal Y; Nebbab A; Gharnaout M; Ghaffor M; Ladjouze A
    Joint Bone Spine; 2013 Oct; 80(5):547-8. PubMed ID: 23541846
    [No Abstract]   [Full Text] [Related]  

  • 9. Cartilage oligomeric matrix protein in systemic sclerosis.
    Yamamoto M; Takahashi H; Suzuki C; Naishiro Y; Yamamoto H; Imai K; Shinomura Y
    Rheumatology (Oxford); 2007 Dec; 46(12):1858-9. PubMed ID: 17895282
    [No Abstract]   [Full Text] [Related]  

  • 10. [Systemic sclerosis with advanced cardio-pulmonary compromise].
    Villa R; Panico N; Oliveri C; Bezante G; Brusasco V; Indiveri F
    Ann Ital Med Int; 2005; 20(2):118-32; quiz 133-5. PubMed ID: 16052846
    [No Abstract]   [Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibodies (ANCA) in ankylosing spondylitis.
    Calvo-Romero JM; Romero-Requena J; Arévalo-Lorido JC
    Clin Exp Rheumatol; 2003; 21(4):528. PubMed ID: 12942715
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis.
    Carvajal I; Bernis C; Sanz P; Garcia A; Garcia-Vadillo A; Traver JA
    Nephrol Dial Transplant; 1997 Mar; 12(3):576-7. PubMed ID: 9075145
    [No Abstract]   [Full Text] [Related]  

  • 14. P-ANCA for ulcerative colitis management-hype or hope?
    Koch TR
    Am J Gastroenterol; 2002 Feb; 97(2):485. PubMed ID: 11866293
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of direct immunofluorescence test in cutaneous leukocytoclastic vasculitis.
    Sais G; Vidaller A
    Int J Dermatol; 2005 Nov; 44(11):970-1; author reply 971. PubMed ID: 16336539
    [No Abstract]   [Full Text] [Related]  

  • 16. Myeloperoxidase-antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl-70-positive scleroderma.
    Cheung G; Chew G; Wyndham R; Peters M; Riminton S
    Intern Med J; 2007 Mar; 37(3):205-7. PubMed ID: 17316347
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement.
    Manetti M; Guiducci S; Ceccarelli C; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Oct; 70(10):1876-8. PubMed ID: 21571732
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated active secretory sphingomyelinase in antineutrophil cytoplasmic antibody-associated primary systemic vasculitis.
    Kiprianos AP; Morgan MD; Little MA; Harper L; Bacon PA; Young SP
    Ann Rheum Dis; 2012 Jun; 71(6):1100-2. PubMed ID: 22219136
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic significance of ANCA in vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):174-5. PubMed ID: 16932679
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
    Koenig M; Dieudé M; Senécal JL
    Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.